Your session is about to expire
← Back to Search
PFN Implant for Hip Fracture
Study Summary
This trial evaluates the safety, efficacy and feasibility of a new device for treating femur fractures, the Artemis PFN, which has been approved by the FDA.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Artemis Proximal Femoral Nail (PFN) implant
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are involved in this experiment?
"Affirmative. According to clinicaltrials.gov, this research continues to seek participants since first being posted on May 24th 2023 and most recently updated June 20th of the same year. The protocol requires a total sample size of twenty patients from one site."
Are there any available slots in this trial for participants?
"Clinicaltrials.gov verifies that this clinical trial is presently enrolling volunteers. This investigation, which commenced on May 24th 2023, was recently updated on June 20th of the same year."
What tangible results are researchers expecting to attain from this clinical trial?
"This 6-month study strives to understand the rate of fracture nonunion. Secondary objectives include measuring financial costs, radiographic evidence of healing, and usage of gait-aid devices like wheelchairs or canes."
Share this study with friends
Copy Link
Messenger